Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Hirst

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|October 3, 2008
CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patientsF G Joseph, C L Hirst, T P Pickersgill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Validity of patient-derived disability and clinical data in multiple sclerosisG Ingram, E Colley, Y Ben-Shlomo, et al.
Journal of Neurology|February 20, 2008
Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosisC L Hirst, A Pace, T P Pickersgill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2012
Systemic complement profiling in multiple sclerosis as a biomarker of disease stateG Ingram, S Hakobyan, C L Hirst, et al.
Journal of Neurology|January 6, 2010
Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathyE A Marsh, C L Hirst, J G Llewelyn, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Neurology, Neurosurgery, and Psychiatry|October 3, 2008
CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patientsF G Joseph, C L Hirst, T P Pickersgill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2010
Validity of patient-derived disability and clinical data in multiple sclerosisG Ingram, E Colley, Y Ben-Shlomo, et al.
Journal of Neurology|February 20, 2008
Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosisC L Hirst, A Pace, T P Pickersgill, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2012
Systemic complement profiling in multiple sclerosis as a biomarker of disease stateG Ingram, S Hakobyan, C L Hirst, et al.
Journal of Neurology|January 6, 2010
Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathyE A Marsh, C L Hirst, J G Llewelyn, et al.
Pageof 1